568 related articles for article (PubMed ID: 32829388)
1. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
[TBL] [Abstract][Full Text] [Related]
2. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
3. Characterization of ovarian tissue oocytes from transgender men reveals poor calcium release and embryo development, which might be overcome by spindle transfer.
Christodoulaki A; He H; Zhou M; Cardona Barberán A; De Roo C; Chuva De Sousa Lopes SM; Baetens M; Menten B; Van Soom A; De Sutter P; Weyers S; Boel A; Stoop D; Heindryckx B
Hum Reprod; 2023 Jun; 38(6):1135-1150. PubMed ID: 37029914
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the scope of in vitro maturation for fertility preservation: transvaginal retrieval of immature oocytes during endoscopic gynaecological procedures.
Song XL; Lu CL; Zheng XY; Nisenblat V; Zhen XM; Yang R; Li M; Li R; Yuan YF; Ma CH; Liu P; Feng HL; Yan J; Qiao J
Hum Reprod; 2020 Apr; 35(4):837-846. PubMed ID: 32154563
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Different In Vitro Maturation Procedures for Oocyte Cryopreservation for Fertility Preservation and yet Another Live Birth in a Cancer Patient.
Nogueira D; Fajau-Prevot C; Clouet M; Assouline P; Deslandres M; Montagut M
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374137
[TBL] [Abstract][Full Text] [Related]
7. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation.
Fraison E; Huberlant S; Labrune E; Cavalieri M; Montagut M; Brugnon F; Courbiere B
Hum Reprod; 2023 Mar; 38(3):489-502. PubMed ID: 36421038
[TBL] [Abstract][Full Text] [Related]
8. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
[TBL] [Abstract][Full Text] [Related]
9. FGF2, LIF, and IGF1 (FLI) supplementation during human in vitro maturation enhances markers of gamete competence.
Amargant F; Zhou LT; Yuan Y; Nahar A; Krisher RL; Spate LD; Roberts RM; Prather RS; Rowell EE; Laronda MM; Duncan FE
Hum Reprod; 2023 Oct; 38(10):1938-1951. PubMed ID: 37608600
[TBL] [Abstract][Full Text] [Related]
10. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
11. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
12. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
13. Prior exposure to chemotherapy does not reduce the in vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients.
Karavani G; Vedder K; Gutman-Ido E; Gruda Sussman R; Goldschmidt N; Mordechai-Daniel T; Ben-Meir A; Imbar T
Hum Reprod; 2023 Sep; 38(9):1705-1713. PubMed ID: 37414543
[TBL] [Abstract][Full Text] [Related]
14. A 10-year follow-up of reproductive outcomes in women attempting motherhood after elective oocyte cryopreservation.
Loreti S; Darici E; Nekkebroeck J; Drakopoulos P; Van Landuyt L; De Munck N; Tournaye H; De Vos M
Hum Reprod; 2024 Feb; 39(2):355-363. PubMed ID: 38145619
[TBL] [Abstract][Full Text] [Related]
15. Positive effects of amphiregulin on human oocyte maturation and its molecular drivers in patients with polycystic ovary syndrome.
Akin N; Le AH; Ha UDT; Romero S; Sanchez F; Pham TD; Nguyen MHN; Anckaert E; Ho TM; Smitz J; Vuong LN
Hum Reprod; 2021 Dec; 37(1):30-43. PubMed ID: 34741172
[TBL] [Abstract][Full Text] [Related]
16. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
17. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
18. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
[TBL] [Abstract][Full Text] [Related]
19. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
[TBL] [Abstract][Full Text] [Related]
20. Definition of a clinical strategy to enhance the efficacy, efficiency and safety of egg donation cycles with imported vitrified oocytes.
Rienzi L; Cimadomo D; Maggiulli R; Vaiarelli A; Dusi L; Buffo L; Amendola MG; Colamaria S; Giuliani M; Bruno G; Stoppa M; Ubaldi FM
Hum Reprod; 2020 Apr; 35(4):785-795. PubMed ID: 32240287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
